Literature DB >> 17675520

Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosin light chain kinase in endothelial tight-junction disorganization.

Philippe Vicente Afonso1, Simona Ozden, Marie-Christine Prevost, Christine Schmitt, Danielle Seilhean, Babette Weksler, Pierre-Olivier Couraud, Antoine Gessain, Ignacio Andres Romero, Pierre-Emmanuel Ceccaldi.   

Abstract

The blood-brain barrier (BBB), which constitutes the interface between blood and cerebral parenchyma, has been shown to be disrupted during retroviral associated neuromyelopathies. Human T cell leukemia virus (HTLV-1)-associated myelopathy/tropical spastic paraparesis is a slowly progressive neurodegenerative disease, in which evidence of BBB breakdown has been demonstrated by the presence of lymphocytic infiltrates in the CNS and plasma protein leakage through cerebral endothelium. Using an in vitro human BBB model, we investigated the cellular and molecular mechanisms involved in endothelial changes induced by HTLV-1-infected lymphocytes. We demonstrate that coculture with infected lymphocytes induces an increase in paracellular endothelial permeability and transcellular migration, via IL-1alpha and TNF-alpha secretion. This disruption is associated with tight junction disorganization between endothelial cells, and alterations in the expression pattern of tight junction proteins such as zonula occludens 1. These changes could be prevented by inhibition of the NF-kappaB pathway or of myosin light chain kinase activity. Such disorganization was confirmed in histological sections of spinal cord from an HTLV-1-associated myelopathy/tropical spastic paraparesis patient. Based on this BBB model, the present data indicate that HTLV-1-infected lymphocytes can induce BBB breakdown and may be responsible for the CNS infiltration that occurs in the early steps of retroviral-associated neuromyelopathies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17675520     DOI: 10.4049/jimmunol.179.4.2576

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation.

Authors:  Olutayo Odusanwo; Sreedevi Chinthamani; Andrew McCall; Michael E Duffey; Olga J Baker
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-11       Impact factor: 4.249

Review 2.  Neuroimmunity of HTLV-I Infection.

Authors:  Eiji Matsuura; Yoshihisa Yamano; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-02       Impact factor: 4.147

3.  Comparison of immortalized bEnd5 and primary mouse brain microvascular endothelial cells as in vitro blood-brain barrier models for the study of T cell extravasation.

Authors:  Oliver Steiner; Caroline Coisne; Britta Engelhardt; Ruth Lyck
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-07       Impact factor: 6.200

4.  Impacts of blood-brain barrier in drug delivery and targeting of brain tumors.

Authors:  Yadollah Omidi; Jaleh Barar
Journal:  Bioimpacts       Date:  2012-02-02

Review 5.  Viral interactions with the blood-brain barrier: old dog, new tricks.

Authors:  Jianghui Hou; Lane A Baker; Lushan Zhou; Robyn S Klein
Journal:  Tissue Barriers       Date:  2016-01-28

6.  Circulating levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases during Japanese encephalitis virus infection.

Authors:  Vibha Shukla; Akhalesh Kumar Shakya; Mukti Shukla; Niraj Kumari; Narendra Krishnani; T N Dhole; Usha Kant Misra
Journal:  Virusdisease       Date:  2016-01-19

7.  Kaposi's sarcoma-associated herpesvirus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin.

Authors:  Li-Wu Qian; Whitney Greene; Fengchun Ye; Shou-Jiang Gao
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

8.  Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner.

Authors:  Yoshifumi Sonobe; Hideyuki Takeuchi; Kunio Kataoka; Hua Li; Shijie Jin; Maya Mimuro; Yoshio Hashizume; Yasuteru Sano; Takashi Kanda; Tetsuya Mizuno; Akio Suzumura
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

Review 9.  The immune system in stroke: clinical challenges and their translation to experimental research.

Authors:  Craig J Smith; Catherine B Lawrence; Beatriz Rodriguez-Grande; Krisztina J Kovacs; Jesus M Pradillo; Adam Denes
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-15       Impact factor: 4.147

10.  Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor.

Authors:  Saguna Verma; Mukesh Kumar; Ulziijargal Gurjav; Stephanie Lum; Vivek R Nerurkar
Journal:  Virology       Date:  2009-11-18       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.